Alvotech

General ticker "ALVO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.9B (TTM average)

Alvotech does not follow the US Stock Market performance with the rate: -12.7%.

Estimated limits based on current volatility of 2.8%: low 4.53$, high 4.93$

Factors to consider:

  • Total employees count: 947 as of 2022
  • Current price 15.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [6.01$, 14.83$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.81$, 12.18$]

Financial Metrics affecting the ALVO estimates:

  • Negative: with PPE of -19.0 at the end of fiscal year the price was very high
  • Negative: Operating cash flow per share per price, % of -7.07 <= 0.33
  • Positive: 7.86 < Operating profit margin, % of 14.22
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -33.79 <= 18.93
  • Positive: Investing cash flow per share per price, % of -0.56 > -0.66
  • Negative: Inventory ratio change, % of 4.31 > 0.84
  • Negative: Industry earnings per price (median), % of 0 <= 0

Similar symbols

Short-term ALVO quotes

Long-term ALVO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $83.03MM $91.43MM $489.68MM
Operating Expenses $429.47MM $446.29MM $420.04MM
Operating Income $-346.44MM $-354.86MM $69.64MM
Non-Operating Income $-205.21MM $-296.19MM $-287.21MM
Interest Expense $91.44MM $134.82MM $157.60MM
R&D Expense $180.62MM $210.83MM $171.31MM
Income(Loss) $-551.65MM $-651.05MM $-217.56MM
Taxes $-38.07MM $-99.32MM $14.30MM
Profit(Loss)* $-513.58MM $-551.73MM $-231.86MM
Stockholders Equity $-564.42MM $-932.49MM $-412.77MM
Inventory $71.47MM $74.43MM $127.89MM
Assets $828.44MM $950.09MM $1,221.40MM
Operating Cash Flow $-312.39MM $-312.19MM $-236.84MM
Capital expenditure $49.00MM $46.47MM $57.00MM
Investing Cash Flow $-63.54MM $-46.34MM $-18.87MM
Financing Cash Flow $424.91MM $301.32MM $297.31MM
Earnings Per Share** $-2.60 $-2.43 $-0.87

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.